{"id":"https://openalex.org/W4281706677","doi":"https://doi.org/10.1038/s41467-022-30902-7","title":"Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation","display_name":"Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation","publication_year":2022,"publication_date":"2022-06-09","ids":{"openalex":"https://openalex.org/W4281706677","doi":"https://doi.org/10.1038/s41467-022-30902-7","pmid":"https://pubmed.ncbi.nlm.nih.gov/35680875","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9184486"},"language":"en","primary_location":{"id":"doi:10.1038/s41467-022-30902-7","doi":"https://doi.org/10.1038/s41467-022-30902-7","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-022-30902-7","pdf_url":"https://www.nature.com/articles/s41467-022-30902-7.pdf","source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41467-022-30902-7.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046135292","display_name":"Suyash Deodhar","orcid":"https://orcid.org/0000-0003-1536-6761","observed_orcids":["https://orcid.org/0000-0003-1536-6761"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suyash Deodhar","raw_affiliation_strings":["Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":"https://orcid.org/0000-0003-1536-6761","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012857107","display_name":"Brady Sillman","orcid":"https://orcid.org/0000-0002-7123-3034","observed_orcids":["https://orcid.org/0000-0002-7123-3034"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brady Sillman","raw_affiliation_strings":["Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA","Nebraska Nanomedicine Production Plant, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":"https://orcid.org/0000-0002-7123-3034","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]},{"raw_affiliation_string":"Nebraska Nanomedicine Production Plant, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018546819","display_name":"Aditya N. Bade","orcid":"https://orcid.org/0000-0003-2511-4461","observed_orcids":["https://orcid.org/0000-0003-2511-4461"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aditya N. Bade","raw_affiliation_strings":["Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064647938","display_name":"Sean N. Avedissian","orcid":"https://orcid.org/0000-0002-0935-6455","observed_orcids":["https://orcid.org/0000-0002-0935-6455"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sean N. Avedissian","raw_affiliation_strings":["Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":"https://orcid.org/0000-0002-0935-6455","affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000852039","display_name":"Anthony T. Podany","orcid":"https://orcid.org/0000-0002-8371-0379","observed_orcids":["https://orcid.org/0000-0002-8371-0379"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony T. Podany","raw_affiliation_strings":["Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023736838","display_name":"JoEllyn McMillan","orcid":"https://orcid.org/0000-0001-6896-5122","observed_orcids":["https://orcid.org/0000-0001-6896-5122"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JoEllyn M. McMillan","raw_affiliation_strings":["Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035613509","display_name":"Nagsen Gautam","orcid":"https://orcid.org/0000-0001-5876-6760","observed_orcids":["https://orcid.org/0000-0001-5876-6760"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nagsen Gautam","raw_affiliation_strings":["Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011794164","display_name":"Brandon W. Hanson","orcid":"https://orcid.org/0009-0007-0740-1201","observed_orcids":["https://orcid.org/0009-0007-0740-1201"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandon Hanson","raw_affiliation_strings":["Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006263846","display_name":"Bhagya Laxmi Dyavar Shetty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bhagya L. Dyavar Shetty","raw_affiliation_strings":["Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076498300","display_name":"Adam M. Szlachetka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Szlachetka","raw_affiliation_strings":["Nebraska Nanomedicine Production Plant, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nebraska Nanomedicine Production Plant, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111461536","display_name":"Morgan Johnston","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Morgan Johnston","raw_affiliation_strings":["Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091602989","display_name":"Michellie Thurman","orcid":"https://orcid.org/0000-0002-7699-1870","observed_orcids":["https://orcid.org/0000-0002-7699-1870"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michellie Thurman","raw_affiliation_strings":["Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071014736","display_name":"Daniel J. Munt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. Munt","raw_affiliation_strings":["Department of Pharmacy Sciences, Creighton University, Omaha, NE, 68178, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Sciences, Creighton University, Omaha, NE, 68178, USA","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061214773","display_name":"Alekha K. Dash","orcid":"https://orcid.org/0000-0002-6630-5865","observed_orcids":["https://orcid.org/0000-0002-6630-5865"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alekha K. Dash","raw_affiliation_strings":["Department of Pharmacy Sciences, Creighton University, Omaha, NE, 68178, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Sciences, Creighton University, Omaha, NE, 68178, USA","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002187093","display_name":"Milica Markovi\u0107","orcid":"https://orcid.org/0000-0002-3998-1833","observed_orcids":["https://orcid.org/0000-0002-3998-1833"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Milica Markovic","raw_affiliation_strings":["Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":"https://orcid.org/0000-0002-3998-1833","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029193787","display_name":"Arik Dahan","orcid":"https://orcid.org/0000-0002-3498-3514","observed_orcids":["https://orcid.org/0000-0002-3498-3514"]},"institutions":[{"id":"https://openalex.org/I124227911","display_name":"Ben-Gurion University of the Negev","ror":"https://ror.org/05tkyf982","country_code":"IL","type":"education","lineage":["https://openalex.org/I124227911"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Arik Dahan","raw_affiliation_strings":["Department of Clinical Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, 84105, Israel"],"raw_orcid":"https://orcid.org/0000-0002-3498-3514","affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Ben-Gurion University of the Negev, Beer-Sheva, 84105, Israel","institution_ids":["https://openalex.org/I124227911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021809794","display_name":"Yazen Alnouti","orcid":"https://orcid.org/0000-0002-3995-3242","observed_orcids":["https://orcid.org/0000-0002-3995-3242"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yazen Alnouti","raw_affiliation_strings":["Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013492390","display_name":"Alborz Yazdi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alborz Yazdi","raw_affiliation_strings":["Exavir Therapeutics, Inc., New York, NY, 10012, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exavir Therapeutics, Inc., New York, NY, 10012, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063958308","display_name":"Bhavesh D. Kevadiya","orcid":"https://orcid.org/0000-0002-9119-7798","observed_orcids":["https://orcid.org/0000-0002-9119-7798","https://orcid.org/0000-0003-4016-132X"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bhavesh D. Kevadiya","raw_affiliation_strings":["Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016509877","display_name":"Siddappa N. Byrareddy","orcid":"https://orcid.org/0000-0002-6889-4640","observed_orcids":["https://orcid.org/0000-0002-6889-4640"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Siddappa N. Byrareddy","raw_affiliation_strings":["Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":"https://orcid.org/0000-0002-6889-4640","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029395581","display_name":"Samuel M. Cohen","orcid":"https://orcid.org/0000-0002-5047-0962","observed_orcids":["https://orcid.org/0000-0002-5047-0962"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel M. Cohen","raw_affiliation_strings":["Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":"https://orcid.org/0000-0002-5047-0962","affiliations":[{"raw_affiliation_string":"Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029066855","display_name":"Benson Edagwa","orcid":"https://orcid.org/0000-0003-1484-9331","observed_orcids":["https://orcid.org/0000-0003-1484-9331"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Benson Edagwa","raw_affiliation_strings":["Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA. benson.edagwa@unmc.edu","Exavir Therapeutics, Inc., New York, NY, 10012, USA. benson.edagwa@unmc.edu","Nebraska Nanomedicine Production Plant, University of Nebraska Medical Center, Omaha, NE, 68198, USA. benson.edagwa@unmc.edu","Nebraska Nanomedicine Production Plant, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":"https://orcid.org/0000-0003-1484-9331","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA. benson.edagwa@unmc.edu","institution_ids":["https://openalex.org/I59130452"]},{"raw_affiliation_string":"Exavir Therapeutics, Inc., New York, NY, 10012, USA. benson.edagwa@unmc.edu","institution_ids":[]},{"raw_affiliation_string":"Nebraska Nanomedicine Production Plant, University of Nebraska Medical Center, Omaha, NE, 68198, USA. benson.edagwa@unmc.edu","institution_ids":["https://openalex.org/I59130452"]},{"raw_affiliation_string":"Nebraska Nanomedicine Production Plant, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058974129","display_name":"Howard Eliot Gendelman","orcid":"https://orcid.org/0000-0002-7831-0370","observed_orcids":["https://orcid.org/0000-0002-7831-0370"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Howard E. Gendelman","raw_affiliation_strings":["Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA. hegendel@unmc.edu","Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA. hegendel@unmc.edu","Exavir Therapeutics, Inc., New York, NY, 10012, USA. hegendel@unmc.edu","Nebraska Nanomedicine Production Plant, University of Nebraska Medical Center, Omaha, NE, 68198, USA. hegendel@unmc.edu","Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA"],"raw_orcid":"https://orcid.org/0000-0002-7831-0370","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA. hegendel@unmc.edu","institution_ids":["https://openalex.org/I59130452"]},{"raw_affiliation_string":"Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA. hegendel@unmc.edu","institution_ids":["https://openalex.org/I59130452"]},{"raw_affiliation_string":"Exavir Therapeutics, Inc., New York, NY, 10012, USA. hegendel@unmc.edu","institution_ids":[]},{"raw_affiliation_string":"Nebraska Nanomedicine Production Plant, University of Nebraska Medical Center, Omaha, NE, 68198, USA. hegendel@unmc.edu","institution_ids":["https://openalex.org/I59130452"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5029066855","https://openalex.org/A5058974129"],"corresponding_institution_ids":["https://openalex.org/I59130452"],"apc_list":{"value":5890,"currency":"USD","value_usd":5890},"apc_paid":{"value":5890,"currency":"USD","value_usd":5890},"fwci":5.1625,"has_fulltext":true,"cited_by_count":45,"citation_normalized_percentile":{"value":0.97016911,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"13","issue":"1","first_page":"3226","last_page":"3226"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.625,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.625,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.2563000023365021,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.04089999943971634,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dolutegravir","display_name":"dolutegravir","score":0.9879999756813049},{"id":"https://openalex.org/keywords/integrase-strand-transfer-inhibitors","display_name":"integrase strand transfer inhibitors","score":0.8870000243186951},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.5680000185966492},{"id":"https://openalex.org/keywords/nanocrystals","display_name":"nanocrystals","score":0.828000009059906},{"id":"https://openalex.org/keywords/parenteral-drug-delivery","display_name":"parenteral drug delivery","score":0.6129999756813049},{"id":"https://openalex.org/keywords/intramuscular-injection","display_name":"intramuscular injection","score":0.6200000047683716},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.6480000019073486},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6510000228881836},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.6899999976158142},{"id":"https://openalex.org/keywords/drug-hydrolysis","display_name":"drug hydrolysis","score":0.4569999873638153},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.3490000069141388}],"concepts":[{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.9375735521316528},{"id":"https://openalex.org/C2779502633","wikidata":"https://www.wikidata.org/wiki/Q937224","display_name":"Dolutegravir","level":5,"score":0.8957997560501099},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6591191291809082},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6372765898704529},{"id":"https://openalex.org/C2778414717","wikidata":"https://www.wikidata.org/wiki/Q423467","display_name":"Atazanavir","level":5,"score":0.6181971430778503},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5301125049591064},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5012600421905518},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.49272826313972473},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.46614351868629456},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4604395627975464},{"id":"https://openalex.org/C14430832","wikidata":"https://www.wikidata.org/wiki/Q412550","display_name":"Integrase","level":3,"score":0.4325733780860901},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3501546382904053},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.21460428833961487},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.19983616471290588},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.15288498997688293},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.09807035326957703},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.06898412108421326},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000099226","descriptor_name":"Dolutegravir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006575","descriptor_name":"Heterocyclic Compounds, 3-Ring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1038/s41467-022-30902-7","doi":"https://doi.org/10.1038/s41467-022-30902-7","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-022-30902-7","pdf_url":"https://www.nature.com/articles/s41467-022-30902-7.pdf","source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},{"id":"doi:10.21203/rs.3.rs-1255147/v1","doi":"https://doi.org/10.21203/rs.3.rs-1255147/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-1255147/v1","pdf_url":"https://www.researchsquare.com/article/rs-1255147/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:9184486","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9184486","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nat Commun","raw_type":"Text"},{"id":"pmid:35680875","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35680875","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature communications","raw_type":"Journal Article"},{"id":"pmh:oai:RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-30902-7","doi":null,"is_oa":false,"landing_page_url":"https://www.nature.com/articles/s41467-022-30902-7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:doaj.org/article:0e6c6ddce7834d67b915c46f752da67f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/0e6c6ddce7834d67b915c46f752da67f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s41467-022-30902-7","doi":"https://doi.org/10.1038/s41467-022-30902-7","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41467-022-30902-7","pdf_url":"https://www.nature.com/articles/s41467-022-30902-7.pdf","source":{"id":"https://openalex.org/S64187185","display_name":"Nature Communications","issn_l":"2041-1723","issn":["2041-1723"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","oarl","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Communications","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1043466707","display_name":"Combined Molecular Excision Therapy (CMET) for Eliminating HIV-1","funder_award_id":"R01MH115860","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G1398244641","display_name":null,"funder_award_id":"P30 MH062261","funder_id":"https://openalex.org/F4320309137","funder_display_name":"University of Nebraska Medical Center"},{"id":"https://openalex.org/G2117518536","display_name":"Center for Humanized Mice","funder_award_id":"R24OD018546","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G2219336220","display_name":"NanoART Manufacture, Delivery and Pharmacokinetics for Optimizing Drug Adherence","funder_award_id":"P01DA028555","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G2529756465","display_name":"Limiting HIV establishment and maintenace by preserving intestinal immunity","funder_award_id":"R01AI129745","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G3186359280","display_name":null,"funder_award_id":"MH121402","funder_id":"https://openalex.org/F4320309137","funder_display_name":"University of Nebraska Medical Center"},{"id":"https://openalex.org/G3556065321","display_name":"Chronic HIV Infection and Aging in NeuroAIDS (CHAIN) Center","funder_award_id":"P30MH062261","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G4426271373","display_name":"Nanomedicine and NeuroAIDS","funder_award_id":"R01NS036126","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G5041077875","display_name":null,"funder_award_id":"R01 Al158160","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G5078303090","display_name":"Novel Adjunctive Therapies for NeuroAIDS","funder_award_id":"P01MH064570","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G5300552297","display_name":"Molecular Mechanisms of HIV-1 Associated Encephalopathy","funder_award_id":"P01NS031492","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G6320211117","display_name":null,"funder_award_id":"R01 AI145342","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000187722","display_name":"Neuroprotective Immunity and HIV Dementia","funder_award_id":"R01NS034239","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G9000262396","display_name":null,"funder_award_id":"NS036126","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000856944","display_name":"LASER ART for PreP","funder_award_id":"R01AI158160","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000862597","display_name":"Neuroimmunology of Disease Training Program","funder_award_id":"T32NS105594","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G9000877012","display_name":"Prodrug Formulations Create Sustained-Release Antiretrovirals","funder_award_id":"R01AI145542","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000896768","display_name":"HIV-1DetectionandEliminationFrom CNS Mononuclear Phagocytes","funder_award_id":"R01NS126089","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G9000914044","display_name":"Targeted lipid nanoparticles for gene therapeutics delivery approach to eradicating HIV reservoirs","funder_award_id":"R01MH121402","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320309137","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16"},{"id":"https://openalex.org/F4320310264","display_name":"University of Nebraska-Lincoln","ror":"https://ror.org/043mer456"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4281706677.pdf","grobid_xml":"https://content.openalex.org/works/W4281706677.grobid-xml"},"referenced_works_count":50,"referenced_works":["https://openalex.org/W238606783","https://openalex.org/W602198522","https://openalex.org/W1755455097","https://openalex.org/W1894318670","https://openalex.org/W1934296086","https://openalex.org/W2017331060","https://openalex.org/W2020783600","https://openalex.org/W2034414496","https://openalex.org/W2131257415","https://openalex.org/W2150795943","https://openalex.org/W2156223436","https://openalex.org/W2220671460","https://openalex.org/W2260708985","https://openalex.org/W2404394069","https://openalex.org/W2486272579","https://openalex.org/W2557331456","https://openalex.org/W2580755549","https://openalex.org/W2738541296","https://openalex.org/W2765161131","https://openalex.org/W2765304030","https://openalex.org/W2766546877","https://openalex.org/W2794081933","https://openalex.org/W2796958178","https://openalex.org/W2802170264","https://openalex.org/W2894851276","https://openalex.org/W2954698528","https://openalex.org/W2964855751","https://openalex.org/W2972081238","https://openalex.org/W2981566974","https://openalex.org/W3005088553","https://openalex.org/W3005614740","https://openalex.org/W3009783198","https://openalex.org/W3013189014","https://openalex.org/W3014830560","https://openalex.org/W3018289581","https://openalex.org/W3028275166","https://openalex.org/W3030006426","https://openalex.org/W3034482583","https://openalex.org/W3044310620","https://openalex.org/W3048563096","https://openalex.org/W3080304633","https://openalex.org/W3082576563","https://openalex.org/W3118804558","https://openalex.org/W3125058209","https://openalex.org/W3166762075","https://openalex.org/W3173517540","https://openalex.org/W3177982925","https://openalex.org/W3201379478","https://openalex.org/W4236405211","https://openalex.org/W4254766317"],"related_works":["https://openalex.org/W7071216715","https://openalex.org/W2802170264","https://openalex.org/W7006157362","https://openalex.org/W3177982925","https://openalex.org/W2766546877","https://openalex.org/W4220721641","https://openalex.org/W3166762075","https://openalex.org/W7125175182","https://openalex.org/W2972997041","https://openalex.org/W2602189150"],"abstract_inverted_index":{"Ultra-long-acting":[0],"integrase":[1,127],"strand":[2],"transfer":[3],"inhibitors":[4],"were":[5],"created":[6],"by":[7,110],"screening":[8],"a":[9,79,124],"library":[10],"of":[11,123],"monomeric":[12],"and":[13,44,63,93,99,121,133,140],"dimeric":[14],"dolutegravir":[15],"(DTG)":[16],"prodrug":[17,27,86,94],"nanoformulations.":[18],"This":[19],"led":[20],"to":[21,34,78,136],"an":[22,104],"18-carbon":[23],"chain":[24],"modified":[25],"ester":[26],"nanocrystal":[28,91],"(coined":[29],"NM2DTG)":[30],"with":[31],"the":[32,42,59],"potential":[33],"sustain":[35],"yearly":[36],"dosing.":[37],"Here,":[38],"we":[39],"show":[40],"that":[41],"physiochemical":[43],"pharmacokinetic":[45],"(PK)":[46],"formulation":[47],"properties":[48],"facilitate":[49],"slow":[50],"drug":[51,73],"release":[52],"from":[53],"tissue":[54],"macrophage":[55],"depot":[56],"stores":[57],"at":[58],"muscle":[60],"injection":[61],"site":[62],"adjacent":[64],"lymphoid":[65],"tissues":[66],"following":[67,81],"single":[68],"parenteral":[69],"injection.":[70,82],"Significant":[71],"plasma":[72],"levels":[74],"are":[75,88],"recorded":[76,109],"up":[77],"year":[80],"Tissue":[83],"sites":[84],"for":[85],"hydrolysis":[87],"dependent":[89],"on":[90],"dissolution":[92],"release,":[95],"drug-depot":[96],"volume,":[97],"perfusion,":[98],"cell-tissue":[100],"pH.":[101],"Each":[102],"affect":[103],"extended":[105],"NM2DTG":[106,114],"apparent":[107],"half-life":[108],"PK":[111],"parameters.":[112],"The":[113],"product":[115],"can":[116],"impact":[117],"therapeutic":[118],"adherence,":[119],"tolerability,":[120],"access":[122],"widely":[125],"used":[126],"inhibitor":[128],"in":[129],"both":[130],"resource":[131],"limited":[132],"rich":[134],"settings":[135],"reduce":[137],"HIV-1":[138],"transmission":[139],"achieve":[141],"optimal":[142],"treatment":[143],"outcomes.":[144]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":14},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":5}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2022-06-13T00:00:00"}